Bayer to Bring Five Drug Candidates Into Late-Stage Clinical Studies By 2015

Bayer is planning to speed up the development of drugs currently undergoing Phase I and II clinical trials. The drugmaker wants the drugs, for oncology, women’s health and cardiology, in Phase III trials by 2015.
Nasdaq